|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
66,383,000 |
Market
Cap: |
1.33(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$16.53 - $28.72 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 2 |
Insider 6 Months : 2 |
Insider 3/6 Months : 4.3 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Xencor is a clinical-stage biopharmaceutical company focused on discovering and developing engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. Co. is developing a portfolio of clinical-stage XmAb® drug candidates from its protein engineering technology platforms. Co.'s XmAb bispecific Fc drug candidates include: Vudalimab (XmAb717), which is a bispecific antibody that targets PD-1 and CTLA-4 and for patients with metastatic castration-resistant prostate cancer and other solid tumor types; and Plamotamab, which is a bispecific antibody that targets CD20, an antigen on B-cell tumors, and CD3, an activating receptor on T cells.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
53 |
53 |
53 |
53 |
Total Buy Value |
$1,013 |
$1,013 |
$1,013 |
$1,013 |
Total People Bought |
1 |
1 |
1 |
1 |
Total Buy Transactions |
1 |
1 |
1 |
1 |
Total Shares Sold |
101,351 |
146,351 |
179,848 |
214,693 |
Total Sell Value |
$2,152,463 |
$3,094,133 |
$3,971,419 |
$5,040,525 |
Total People Sold |
5 |
5 |
5 |
6 |
Total Sell Transactions |
10 |
11 |
12 |
27 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Baracchini Edgardo Jr |
Chief Business Officer |
|
2018-03-02 |
4 |
OE |
$0.59 |
$5,900 |
D/D |
10,000 |
10,000 |
|
- |
|
Baracchini Edgardo Jr |
Chief Business Officer |
|
2018-02-27 |
4 |
AS |
$29.64 |
$592,848 |
D/D |
(20,000) |
0 |
|
- |
|
Baracchini Edgardo Jr |
Chief Business Officer |
|
2018-02-27 |
4 |
OE |
$0.59 |
$11,800 |
D/D |
20,000 |
20,000 |
|
- |
|
Baracchini Edgardo Jr |
Chief Business Officer |
|
2018-02-22 |
4 |
AS |
$26.00 |
$209,794 |
D/D |
(8,069) |
0 |
|
- |
|
Baracchini Edgardo Jr |
Chief Business Officer |
|
2018-02-22 |
4 |
OE |
$0.59 |
$4,761 |
D/D |
8,069 |
8,069 |
|
- |
|
Foster Paul A |
Chief Medical Officer |
|
2018-02-22 |
4 |
AS |
$26.03 |
$260,300 |
D/D |
(10,000) |
2,419 |
|
- |
|
Foster Paul A |
Chief Medical Officer |
|
2018-02-22 |
4 |
OE |
$0.59 |
$5,900 |
D/D |
10,000 |
12,419 |
|
- |
|
Foster Paul A |
Chief Medical Officer |
|
2018-02-16 |
4 |
AS |
$25.01 |
$125,050 |
D/D |
(5,000) |
2,419 |
|
- |
|
Foster Paul A |
Chief Medical Officer |
|
2018-02-16 |
4 |
OE |
$0.59 |
$2,950 |
D/D |
5,000 |
7,419 |
|
- |
|
Ronin Capital, Llc |
10% Owner |
|
2017-12-14 |
4 |
B |
$20.84 |
$62,505 |
I/I |
3,000 |
5,511,348 |
1.5 |
- |
|
Ronin Capital, Llc |
10% Owner |
|
2017-12-12 |
4 |
B |
$20.72 |
$128,775 |
I/I |
6,215 |
5,508,348 |
1.5 |
- |
|
Ronin Capital, Llc |
10% Owner |
|
2017-11-28 |
4 |
B |
$19.86 |
$199,097 |
I/I |
10,025 |
5,502,133 |
1.5 |
- |
|
Ronin Capital, Llc |
10% Owner |
|
2017-11-24 |
4 |
B |
$19.85 |
$106,178 |
I/I |
5,349 |
5,492,108 |
1.5 |
- |
|
Ronin Capital, Llc |
10% Owner |
|
2017-11-10 |
4 |
B |
$19.90 |
$6,448 |
I/I |
324 |
5,485,183 |
1.5 |
- |
|
Ronin Capital, Llc |
10% Owner |
|
2017-11-09 |
4 |
B |
$19.91 |
$758,551 |
I/I |
38,099 |
5,484,859 |
1.5 |
- |
|
Ronin Capital, Llc |
10% Owner |
|
2017-11-08 |
4 |
B |
$19.89 |
$67,609 |
I/I |
3,400 |
5,446,760 |
1.5 |
- |
|
Ronin Capital, Llc |
10% Owner |
|
2017-11-07 |
4 |
B |
$19.89 |
$447,413 |
I/I |
22,500 |
5,443,360 |
1.5 |
- |
|
Ronin Capital, Llc |
10% Owner |
|
2017-11-06 |
4 |
B |
$19.92 |
$6,076 |
I/I |
305 |
5,420,860 |
1.5 |
- |
|
Ronin Capital, Llc |
10% Owner |
|
2017-11-03 |
4 |
B |
$19.68 |
$98,454 |
I/I |
5,004 |
5,420,555 |
1.5 |
- |
|
Ronin Capital, Llc |
10% Owner |
|
2017-11-02 |
4 |
B |
$19.11 |
$101,436 |
I/I |
5,308 |
5,415,551 |
1.5 |
- |
|
Ronin Capital, Llc |
10% Owner |
|
2017-11-01 |
4 |
B |
$19.56 |
$606,204 |
I/I |
30,992 |
5,410,243 |
1.5 |
- |
|
Ronin Capital, Llc |
10% Owner |
|
2017-10-31 |
4 |
B |
$19.81 |
$271,397 |
I/I |
13,700 |
5,379,251 |
1.5 |
- |
|
Ronin Capital, Llc |
10% Owner |
|
2017-10-27 |
4 |
B |
$19.88 |
$993,750 |
I/I |
50,000 |
5,365,551 |
1.5 |
- |
|
Ronin Capital, Llc |
10% Owner |
|
2017-10-26 |
4 |
B |
$19.70 |
$1,483,959 |
I/I |
75,347 |
5,315,551 |
1.5 |
- |
|
Ronin Capital, Llc |
10% Owner |
|
2017-10-25 |
4 |
B |
$20.01 |
$493,183 |
I/I |
24,653 |
5,240,204 |
1.5 |
- |
|
312 Records found
|
|
Page 7 of 13 |
|
|